ArticleMusculoskeletal care2026
Occurrence of Undiagnosed Diabetes Mellitus With Musculoskeletal Disorders of the Upper Extremity: Prospective Screening With Point-of-Care Haemoglobin A1c Fingerstick Testing.
Article in Musculoskeletal care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionUpper extremity conditions such as carpal tunnel syndrome (CTS) are more prevalent in patients with diabetes mellitus (DM) than in the general population. This prospective study aimed to determine the viability of DM screening for patients presenting with upper extremity musculoskeletal disorders in an orthopaedic hand clinic and to inform future testing criteria for orthopaedic surgeons.
methodsPatients with a diagnosis of CTS, trigger finger, Dupuytren's contracture, and/or De Quervain's disease were prospectively enroled. Eighty-four patients (60.7% female, 60.0% White) underwent point-of-care haemoglobin A1c (HbA1c) fingerstick testing at their appointment at the orthopaedic surgeon's office. Patient demographics and disease characteristics (symptom laterality, diagnosis of upper extremity pathologies) were collected and compared between patients with HbA1c within normal limits (HbA1c < 5.7) and in the range of prediabetes or type 2 DM (HbA1c ≥ 5.7).
resultsAmong 84 patients, 58.3% had HbA1c in the range of prediabetes and 4.8% in the T2DM range. The most prevalent upper extremity condition was trigger finger (78.6%), and 62.1% of patients presenting with trigger finger had elevated HbA1c. Among patients with prediabetes/T2DM, 43.4% did not have a primary care provider. Patients with elevated HbA1c were significantly more likely to have unilateral symptoms (p = 0.03) and be female (p = 0.008).
conclusionsHand surgeons can successfully identify patients with elevated HbA1c, particularly in the range of prediabetes where the disease state is more reversible. Point-of-care HbA1c testing could be incorporated into hand surgery practices as a low-cost and rapid intervention to optimise outcomes of surgery and facilitate earlier treatment of hyperglycemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.